Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - STOCK-BASED COMPENSATION
Stock-based Compensation NTLA - Intellia Therapeutics, Inc.
134 M
LAST VALUE
68.87%
2 YEAR CAGR
51.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR